TRC 2004 Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $90M

  • Investors
  • 1

TRC 2004 General Information

Description

Developer of bispecific T-cell engager antibodies designed to target and deplete specific populations of B lymphocytes, which contribute to autoimmune diseases. The company develops immunotherapies to eliminate harmful B cells while preserving overall immune function, enabling healthcare providers to manage severe autoimmune conditions effectively through selective B cell depletion.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11622 El Camino Real
  • Suite 150
  • San Diego, CA 92130
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 11622 El Camino Real
  • Suite 150
  • San Diego, CA 92130
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TRC 2004 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 13-Sep-2024 $90M Completed Startup
2. Merger/Acquisition 09-Sep-2024 Completed Startup
1. Joint Venture 01-Jan-2020 Completed Startup
To view TRC 2004’s complete valuation and funding history, request access »

TRC 2004 Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Two River Group Venture Capital Majority
To view TRC 2004’s complete investors history, request access »

TRC 2004 FAQs

  • When was TRC 2004 founded?

    TRC 2004 was founded in 2020.

  • Where is TRC 2004 headquartered?

    TRC 2004 is headquartered in San Diego, CA.

  • What industry is TRC 2004 in?

    TRC 2004’s primary industry is Drug Discovery.

  • Is TRC 2004 a private or public company?

    TRC 2004 is a Private company.

  • What is TRC 2004’s current revenue?

    The current revenue for TRC 2004 is .

  • How much funding has TRC 2004 raised over time?

    TRC 2004 has raised $90M.

  • Who are TRC 2004’s investors?

    Two River Group has invested in TRC 2004.

  • When was TRC 2004 acquired?

    TRC 2004 was acquired on 13-Sep-2024.

  • Who acquired TRC 2004?

    TRC 2004 was acquired by Candid Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process